Green Thumb Industries (GTBIF) Share-based Compensation (2019 - 2026)
Green Thumb Industries (GTBIF) reported Share-based Compensation of $10.5 million for Q1 2026, up 2.02% on a YoY basis from $10.3 million in Q1 2025, and down 4.43% quarter-over-quarter from $11.0 million in Q4 2025.
Green Thumb Industries (GTBIF) Share-based Compensation (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Share-based Compensation for 8 years, with the latest figure at $10.5 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 2.02% year-over-year to $10.5 million; the trailing twelve-month figure through Mar 2026 stood at $45.1 million (up 21.57% YoY), and the FY2025 full-year result was $44.9 million, up 34.89% from the prior year.
- Share-based Compensation for Q1 2026 stood at $10.5 million, down from $11.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $12.0 million in Q2 2025, with the low at $4.7 million in Q1 2022.
- Historically, Share-based Compensation has averaged $8.5 million across 5 years, with a median of $7.9 million in 2022.
- Annual changes were most pronounced in 2023 — Share-based Compensation dropped 8.42% — and 2025, when it surged 58.84%.
- Green Thumb Industries' Share-based Compensation stood at $7.8 million in 2022, then slipped by 5.45% to $7.4 million in 2023, then soared by 30.64% to $9.6 million in 2024, then grew by 14.54% to $11.0 million in 2025, then fell by 4.43% to $10.5 million in 2026.
- The last three Share-based Compensation figures came in at $10.5 million (Q1 2026), $11.0 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 10.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.52 Mn |
| Mar 31, 2026 | 10.52 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | 11.65 Mn |
| Sep 30, 2025 | 11.65 Mn |
| Jun 30, 2025 | 11.97 Mn |
| Jun 30, 2025 | 11.97 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Dec 31, 2024 | 9.61 Mn |
| Dec 31, 2024 | 9.61 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 8.87 Mn |
| Jun 30, 2024 | 8.87 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Dec 31, 2023 | 7.35 Mn |